Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-09-07

FDA Approved: CLOPIDOGREL — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approved a supplemental application for clopidogrel bisulfate (generic clopidogrel) by Apotex Corp., under the ANDA, authorizing a modification or addition …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOPIDOGREL (CLOPIDOGREL)

Snippet

SUPPL AP for CLOPIDOGREL (CLOPIDOGREL BISULFATE)